Ildong Holdings Co., Ltd.
KSC: 000230.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Woongseop Yoon
- Employees
- 80
- Headquarters
- Seoul, South Korea
- IPO year
- 2000
- Market cap
- ₩101.7B
- Website
- https://www.ildongholdings.co.kr
Loading 000230…
Loading profile data…Frequently asked questions about 000230
What does Ildong Holdings Co., Ltd. (000230.KS) do?
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin...
Where does 000230.KS trade?
Ildong Holdings Co., Ltd. (000230.KS) trades on the Korea Exchange.
What sector is 000230.KS in?
Ildong Holdings Co., Ltd. (000230.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Ildong Holdings Co., Ltd.?
Woongseop Yoon is the chief executive officer of Ildong Holdings Co., Ltd. (000230.KS).
Where is Ildong Holdings Co., Ltd. headquartered?
Ildong Holdings Co., Ltd. is headquartered in South Korea.
Does 000230.KS pay a dividend?
Yes — Ildong Holdings Co., Ltd. (000230.KS) paid a trailing twelve-month dividend of KRW 100.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 000230.KS go public?
Ildong Holdings Co., Ltd. (000230.KS) completed its initial public offering in 2000.